Biotech & Medtech
Biotech & Medtech news — Sunday 01 November 2026
5 stories from 1 sources, every one in English. Each links to its publisher.
-
Midstream Health Snags $20M to Provide Health Systems More Financial Stability
MedCity News
Midstream’s Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and CommonSpirit Ventures. The post Midstream Health Snags $20M to Provide Health Systems More Financial Stability appeared…
-
Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic
MedCity News
Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease type 2C and the prevalent condition overactive bladder. This small molecule came from Actio Biosciences, which was…
-
MMI Raises $125M to Expand Robotic Microsurgery and Explore New Treatments
MedCity News
Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical System and investigate new applications for microsurgery, including an experimental approach to treat Alzheimer’s…
-
What the Midterms Mean for Healthcare and the Investors Betting on It
MedCity News
One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near and long term – here are 3 possible outcomes The post What the Midterms Mean for Healthcare and the Investors…
-
Prestige Is a Business Model
MedCity News
An employer that treats board disclosure, community benefit reporting, and contracting terms as three separate conversations is missing that they are the same conversation. The post Prestige Is a Business Model appeared first on MedCity…